Reducing Substance Use-Related Harms: A Simulation-Optimization Framework for the Design and Evaluation of Harm Reduction Vending Machines

IntroductionThis study introduces a simulation-optimization framework designed to optimize the services of opioid-focused harm reduction vending machines (HRVMs). Given the rising rates of overdose deaths and increased potential for infectious diseases among persons who inject drugs (PWID), HRVMs can become an important harm reduction (HR) strategy by providing essential supplies that mitigate health risks.MethodsWe developed and validated an agent-based simulation-optimization framework to model the impact of HRVM-item allocation on the burden of opioid-related harms, accounting for demand dynamics, item restocking, and regional characteristics. The model evaluated health outcomes-cases of HIV, HCV, and fatal and nonfatal overdose-using disability-adjusted life-years (DALYs). Scenario-based analyses were conducted for different HRVM configurations, considering current legal limits on safer-injection supplies, fentanyl's growing role as a drug of choice, and potential future policy changes.ResultsThe base scenario estimated optimal HRVM capacity allocation at approximately 48.5% fentanyl test strips (FTS), 26.2% naloxone, and 25.3% safer injection kits. However, sensitivity analyses showed significant variations based on fentanyl prevalence and willingness to use FTS. In scenarios of intentional fentanyl use with high FTS utilization, allocation favored FTS, while scenarios with low FTS utilization prioritized naloxone and injection kits. Adding addiction treatment referral services to HRVMs further reduced DALYs and societal costs, primarily by preventing fatal overdoses. Safer injection kits consistently reduced blood-borne infections compared with scenarios without these kits.ConclusionsThe framework could aid in HRVMãrelated service planning and evaluation, highlighting the importance of strategic inventory management and linkages to addiction care for enhanced health outcomes. HRVMs show potential as scalable, cost-effective HR interventions, warranting further research on their impact on service accessibility and health outcomes.HighlightsA novel simulation-optimization framework for designing and evaluating harm reduction vending machines (HRVMs) is presented.Optimal baseline allocation for products in the HRVMs included fentanyl test strips (48.5%), naloxone (26.2%), and safer injection kits (25.3%).Sensitivity analysis indicated optimal allocations vary substantially by local fentanyl prevalence and by individual harm reduction behaviors surrounding the use of fentanyl test strips.HRVM implementation reduces societal costs and disability-adjusted life-years associated with substance use-related harms.

Authors

Institutions

Publication Details

Journal
Medical Decision Making
Published
2025-09-24
DOI
https://doi.org/10.1177/0272989x251367719
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reducing Substance Use-Related Harms: A Simulation-Optimization Framework for the Design and Evaluation of Harm Reduction Vending Machines

Aleksandra E Zgierska, Alice Zhang, Reyhaneh Zafarnejad, Paul M. Griffin
Medical Decision Making
Opioid Use Disorder Treatment
article

Reducing Substance Use-Related Harms: A Simulation-Optimization Framework for the Design and Evaluation of Harm Reduction Vending Machines

Aleksandra E Zgierska, Alice Zhang, Reyhaneh Zafarnejad, Paul M. Griffin
article en

Abstract

IntroductionThis study introduces a simulation-optimization framework designed to optimize the services of opioid-focused harm reduction vending machines (HRVMs). Given the rising rates of overdose deaths and increased potential for infectious diseases among persons who inject drugs (PWID), HRVMs can become an important harm reduction (HR) strategy by providing essential supplies that mitigate health risks.MethodsWe developed and validated an agent-based simulation-optimization framework to model the impact of HRVM-item allocation on the burden of opioid-related harms, accounting for demand dynamics, item restocking, and regional characteristics. The model evaluated health outcomes-cases of HIV, HCV, and fatal and nonfatal overdose-using disability-adjusted life-years (DALYs). Scenario-based analyses were conducted for different HRVM configurations, considering current legal limits on safer-injection supplies, fentanyl's growing role as a drug of choice, and potential future policy changes.ResultsThe base scenario estimated optimal HRVM capacity allocation at approximately 48.5% fentanyl test strips (FTS), 26.2% naloxone, and 25.3% safer injection kits. However, sensitivity analyses showed significant variations based on fentanyl prevalence and willingness to use FTS. In scenarios of intentional fentanyl use with high FTS utilization, allocation favored FTS, while scenarios with low FTS utilization prioritized naloxone and injection kits. Adding addiction treatment referral services to HRVMs further reduced DALYs and societal costs, primarily by preventing fatal overdoses. Safer injection kits consistently reduced blood-borne infections compared with scenarios without these kits.ConclusionsThe framework could aid in HRVMãrelated service planning and evaluation, highlighting the importance of strategic inventory management and linkages to addiction care for enhanced health outcomes. HRVMs show potential as scalable, cost-effective HR interventions, warranting further research on their impact on service accessibility and health outcomes.HighlightsA novel simulation-optimization framework for designing and evaluating harm reduction vending machines (HRVMs) is presented.Optimal baseline allocation for products in the HRVMs included fentanyl test strips (48.5%), naloxone (26.2%), and safer injection kits (25.3%).Sensitivity analysis indicated optimal allocations vary substantially by local fentanyl prevalence and by individual harm reduction behaviors surrounding the use of fentanyl test strips.HRVM implementation reduces societal costs and disability-adjusted life-years associated with substance use-related harms.

Medical Decision MakingVol. 45(8)
Brigham and Women's Hospital (US), Pennsylvania State University (US), Harvard University (US), California Consortium of Addiction Programs and Professionals (US), Penn State Milton S. Hershey Medical Center (US)
Openalex Percentile: Top 65%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.